Increased CSF phosphorylated tau, increased CSF total tau, and decreased CSF β-amyloid levels were associated with visit-to-to-visit blood pressure variability indicating its role in altering AD biomarkers [183]. This evidence concerns the gene MAPT and Alzheimer disease.